Urban renewal in modern industrial economies is rarely just about real estate; it is about reinventing physical infrastructure to house the industries of tomorrow. A striking example of this transformation is unfolding in Beijing's Haidian District, where a former hardware factory dating back to 1958 has been converted into Jinnovation Park-Coresci. Now equipped with high ceilings reaching up to 10 meters and floor load capacities of 1.6 tonnes per square meter, these legacy workshops are being retrofitted to accommodate fermenters, enzyme-reaction vessels, and automated robotics assembly lines. This physical metamorphosis illustrates how China is successfully strengthening the critical links between laboratory research, pilot-scale testing, and commercial manufacturing under the strategic framework of its 15th Five-Year Plan (2026-2030).
A central bottleneck in advanced manufacturing and biomanufacturing has always been the "valley of death" between initial R&D and full-scale commercial production. To bridge this gap, ambitious startups are stepping up. HealthSyn Biotechnology is establishing a specialized pilot-scale testing and demonstration facility for complex human milk oligosaccharides, while Beijing Shuimu Dongfang Medical Technology is operating a dedicated contract development and manufacturing organization (CDMO) platform for high-end medical robots. These shared platforms address a vital market need by providing early regulatory support, clinical resources, and process expertise. With national initiatives aiming to cultivate over 20 pilot-scale testing platforms for biomanufacturing by 2027 to serve more than 200 enterprises and incubate over 400 products, these localized ecosystems are dramatically reducing time-to-market metrics and lowering operational capital expenditure hurdles for early-stage innovators by an estimated 25% to 30%.
Beyond individual facilities, the true economic multiplier lies in co-location driving cross-sector collaboration and supply chain integration. By positioning startups near premier research institutions like Tsinghua University, Peking University, and the Chinese Academy of Sciences in Zhongguancun, the park fosters a dense innovation cluster spanning biomanufacturing, advanced materials, and embodied intelligence. Humanoid robotics firms like Guohua Dingli are leveraging this shared ecosystem to build local joint-production and final assembly lines where tenants naturally become customers, driving efficiency gains across the board. As highlighted in coverage by People's Daily, this seamless integration of legacy industrial space with cutting-edge future industries accelerates the replacement of old growth drivers with high-quality, high-value manufacturing capabilities.
News source: https://peoplesdaily.pdnews.cn/china/er/30052773377